Genomics-based characterization and personalized therapy of advanced thymic epithelial tumors

被引：0

作者：

Moehrmann, L. ^{[1
]}

Rostock, L. ^{[1
]}

Oles, M. ^{[2
,3
]}

Jahn, A. ^{[4
]}

Arlt, M. ^{[4
]}

Paramasivam, N. ^{[2
,3
]}

Joehrens, K. ^{[5
]}

Rupp, L. ^{[6
]}

Schmitz, M. ^{[6
]}

Richter, D. ^{[1
]}

Uhrig, S. ^{[2
,3
]}

Froehlich, M. ^{[2
,3
]}

Hutter, B. ^{[2
,3
]}

Huellein, J. ^{[2
,3
]}

Wolf, E. E. ^{[1
]}

Hanf, D. ^{[1
]}

Gieldon, L. ^{[7
]}

Kreutzfeldt, S. ^{[2
,8
]}

Heilig, C. E. ^{[2
,8
]}

Teleanu, V. ^{[2
,8
]}

Lipka, D. B. ^{[2
,8
]}

Mock, A. ^{[9
]}

Jelas, I. ^{[10
,11
]}

Rieke, D. T. ^{[10
,11
]}

Wiesweg, M. ^{[12
]}

Boerries, M. ^{[13
]}

Illert, A. L. ^{[14
]}

Desuki, A. ^{[15
]}

Kindler, T. ^{[15
]}

Krackhardt, A. M. ^{[16
]}

Westphalen, C. B. ^{[17
,18
]}

Grosch, H. ^{[19
]}

Apostolidis, L. ^{[2
,20
]}

Stenzinger, A. ^{[21
,22
]}

Kerle, I. A. ^{[1
]}

Horak, P. ^{[8
]}

Heining, C. ^{[1
]}

Huebschmann, D. ^{[2
,3
]}

Schroeck, E. ^{[4
]}

Froehling, S. ^{[2
,8
]}

Glimm, H. ^{[1
]}

机构：

[1] Natl Ctr Tumor Dis NCT UCC Dresden, Translat Med Oncol, Dresden, Germany

[2] NCT Heidelberg, Heidelberg, Germany

[3] German Canc Res Ctr, Computat Oncol Grp, Mol Precis Oncol Program, Heidelberg, Germany

[4] Tech Univ Dresden, Inst Clin Genet, Dresden, Germany

[5] Univ Hosp Carl Gustav Carus, Dept Pathol, Dresden, Germany

[6] Tech Univ Dresden, Inst Immunol, Fac Med Carl Gustav Carus, Dresden, Germany

[7] Carl von Ossietzky Univ Oldenburg, Inst Med Genet, Oldenburg, Germany

[8] DKFZ, Translat Med Oncol, Heidelberg, Germany

[9] Ludwig Maximilians Univ Munchen LMU, Inst Pathol, Munich, Germany

[10] Free Univ Berlin, Univ Med Berlin, Charite Comprehens Canc Ctr, Berlin, Germany

[11] Humboldt Univ, Berlin, Germany

[12] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany

[13] Univ Freiburg, Inst Med Bioinformat & Syst Med, Med Ctr, Fac Med, Freiburg, Germany

[14] Univ Freiburg, Dept Internal Med 1, Med Ctr, Fac Med, Freiburg, Germany

[15] Univ Med Ctr Mainz, Univ Canc Ctr, Mainz, Germany

[16] TUM, Klinikum Rechts Isar, Sch Med, Klin & Poliklin Innere Med 3, Munich, Germany

[17] Ludwig Maximilians Univ Munchen, Univ Hosp, Munich, Germany

[18] Comprehens Canc Ctr, Dept Internal Med 3, Munich, Germany

[19] Univ Heidelberg Hosp, Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany

[20] Heidelberg Univ Hosp, Dept Med Oncol, Heidelberg, Germany

[21] Univ Hosp Heidelberg, Heidelberg, Germany

[22] Inst Pathol, Heidelberg, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V973

引用

页码：144 / 144

页数：1

共 50 条

[31] Somatostatin Analogs as mainteinance therapy in heavily pretreated thymic epithelial tumors
Palmieri, G.
Ottaviano, M.
Nappi, L.
Rescigno, P.
Marino, M.
Montella, L.
Micillo, M.
Palumbo, G.
Del Vecchio, S.
Matano, E.
Damiano, V.
ANNALS OF ONCOLOGY, 2015, 26 : 82 - 82
[32] Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy
Yang, Yehao
Yu, Ying
Fan, Yun
Li, Hui
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05):
[33] Genomic characterization of thymic epithelial tumors in a real-world dataset
Kurokawa, K.
Shukuya, T.
Greenstein, R. A.
Kaplan, B. G.
Wakelee, H.
Ross, J. S.
Miura, K.
Furuta, K.
Kato, S.
Suh, J.
Sivakumar, S.
Sokol, E. S.
Carbone, D. P.
Takahashi, K.
ESMO OPEN, 2023, 8 (05)
[34] PRIMARY CULTURES OF HUMAN THYMIC EPITHELIAL TUMORS - MORPHOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERIZATION
PAPADOPOULOS, T
KIRCHNER, T
MARX, A
MULLERHERMELINK, HK
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1989, 56 (06) : 363 - 370
[35] Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors
Chang-Lu Wang
Lan-Ting Gao
Chang-Xing Lyu
Qin Zhang
Wan-Qin Zeng
Wen-Tao Fang
Lei Zhu
Xiao-Long Fu
Medical Oncology, 2022, 39
[36] IMMUNE CORRELATES OF CLINICAL RESPONSE TO AVELUMAB IN PATIENTS WITH ADVANCED THYMIC EPITHELIAL TUMORS
Tsai, Yo-Ting
Rajan, Arun
Gulley, James
Schlom, Jeffrey
Donahue, Renee
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A181 - A181
[37] Chemotherapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Du Vignaux, Claire Merveilleux
Bluthgen, Maria
Mhanna, Laurent
Dansin, Eric
Greillier, Laurent
Pichon, Eric
Lena, Herve
Clement-Duchene, Christelle
Massard, Gilbert
Westeel, Virginie
Robert, Marie
Quantin, Xavier
Zalcman, Gerard
Thiberville, Luc
Molina, Thierry
Mazieres, Julien
Besse, Benjamin
Girard, Nicolas
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S997 - S998
[38] Functional imaging as a tool in individualized treatment in advanced thymic epithelial tumors.
Palmieri, Giovannella
Ottaviano, Margaret
Del Vecchio, Silvana
Segreto, Sabrina
Marino, Mirella
Damiano, Vincenzo
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[39] Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors
Wang, Chang-Lu
Gao, Lan-Ting
Lyu, Chang-Xing
Zhang, Qin
Zeng, Wan-Qin
Fang, Wen-Tao
Zhu, Lei
Fu, Xiao-Long
MEDICAL ONCOLOGY, 2022, 39 (02)
[40] Somatostatin analogs as mainteinance therapy in heavily pretreated thymic epithelial tumors.
Palmieri, Giovannella
Ottaviano, Margaret
Nappi, Lucia
Rescigno, Pasquale
Marino, Mirella
Montella, Liliana
Micillo, Mariateresa
Palumbo, Giuliano
Del Vecchio, Silvana
Damiano, Vincenzo
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →